Study Stopped
insufficient data quality
Treatment of Microscopic Colitis
1 other identifier
interventional
105
1 country
9
Brief Summary
The study compares the effect of Budesonide, Bismuth and fiber in patients with microscopic colitis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2001
Longer than P75 for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2001
CompletedFirst Submitted
Initial submission to the registry
September 10, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedJanuary 21, 2015
January 1, 2015
8.8 years
September 10, 2005
January 20, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Symptoms: Stool frequency and consistency
September 2010: Patient's enrollment completed. Data analysis ongoing.
2001 - 2011
Secondary Outcomes (1)
Histological findings in biopsies from colon
2001 - 2011
Study Arms (3)
Budesonide
EXPERIMENTALBudesonide 9mg
bismuth
EXPERIMENTALBismuth mixture
Fiber
SHAM COMPARATORFiber preparation
Interventions
Eligibility Criteria
You may qualify if:
- Microscopic colitis verified with biopsies from the colon
- Symptoms to such an extent that treatment is indicated
- Age \> 17 years
- Informed consent
You may not qualify if:
- Previous treatment with any of the investigational drugs
- Patients treated with ketoconazole
- Pregnant and breast-feeding females
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- AstraZenecacollaborator
Study Sites (9)
Aust-Agder Sentralsjukehus
Arendal, Norway
Sykehuset Innlandet HF, Gjøvik
Gjøvik, 2819, Norway
Sykehuset Innlandet, HF, Hamar
Hamar, Norway
Sykehuset Innlandet HF, Lillehammer
Lillehammer, Norway
Helse NordMøre og Romsdal
Molde, Norway
Akershus Universitetssykehus
Nordbyhagen, Norway
Aker sykehus
Oslo, Norway
Rikshopitalet
Oslo, Norway
St. Olavs Hospital
Trondheim, 7006, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Per G Farup, PhD
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 10, 2005
First Posted
September 16, 2005
Study Start
November 1, 2001
Primary Completion
September 1, 2010
Study Completion
October 1, 2014
Last Updated
January 21, 2015
Record last verified: 2015-01